OVARIAN CANCER

Common complications of ovarian cancer tumor rupture, hemorrhage, secondary infection, anemia, cancer of the intestine cancer and intestinal infarction colic.

Tags: abdominal, age, anti, benign, body, breast, cancer, carcinoma, cases, cause, cell, chemotherapy, cyst, cystic, cysts, diagnosis, early, eat, examination, gene, grams, increased, malignant, mass, ovarian, pain, patients, pelvic, response, risk, second, surgery, symptoms, syndrome, tea, therapy, time, treatment, tumor, tumors, usually, uterine, women

Treatment of ovarian cancer is still surgery and chemotherapy, although postoperative adjuvant systemic chemotherapy has been the effect certainly, but in some patients because of poor health and not systemic tolerance of the boil, and in some patients for fear of adverse reactions of chemotherapy automatically abandon further treatment, which greatly affects the quality of life and survival rate , an increase of ovarian cancer recurrence possible. The TCM adjuvant treatment of patients with chemotherapy can improve and the tolerance level of immunity and, therefore, Chinese medicine treatment of ovarian cancer has been more and more attention.

Tags: age, bleeding, cancer, cause, chemotherapy, cisplatin, clinical, drug, drugs, eat, ert, gene, injection, intravenous, knowledge, life, ovarian, patients, poor, prognosis, quality, rate, second, surgery, survival, symptoms, therapy, time, treatment, tumor, tumors

(1) of ovarian cancer there are three types of pathology

① primary cancers: Primary ovarian in itself, is generally solid, tumor size, a sustained round, smooth surface, may have nodules processes. Biopsy showed gray ash or red, hard soft different microscope showed various types, such as adenocarcinoma, medullary carcinoma. The beginning is often unilateral, often late into bilateral, the other side of ovarian cancer may be primary, or it may be transferred from the contralateral.

② secondary cancer: from ovarian or other cystadenoma from malignant ovarian tumor.

Tags: abdominal, anti, blood, breast, cancer, carcinoma, cause, cell, cyst, gene, lymph, malignant, mass, metastasis, metastatic, node, ovarian, ovary, second, surface, tumor, usually, uterine

A concept
Ovarian cysts are generalized on an ovarian tumor, all ages are sick, but the most aged 20-50. The prevalence of ovarian cancer rarely sick, so early diagnosis difficult, attendance at the 70% already advanced, little access to early treatment, five-year survival rate always hovering in the 20-30%, the threat to women's lives one of the most serious cancer, ovarian is smaller organ in the human body but for a good variety of tumor site, ovarian cancer can have a variety of nature and form - a single - or mixed type, or of the bilateral side, cystic or substantive, benign or malignant, and many women have ovarian tumors or male sex hormones.

Tags: abdominal, age, anti, benign, bleeding, body, cancer, cause, clinical, cyst, cystic, cysts, diagnosis, early, eat, eggs, ert, examination, gene, growth, gynecological, increased, malignant, mass, oppression, ovarian, pain, patients, pelvic, rate, second, survival, symptoms, treatment, tumor, tumors, usually, women

Ovarian cancer

Tags: age, amenorrhea, blood, body, cancer, cause, cell, cells, early, ert, gene, growth, gynecological, incidence, increased, ovarian, second, tumor, tumors, women

Ovarian cancer is the worst prognosis of gynecologic tumors. Patients with advanced epithelial ovarian cancer five-year survival rates generally below 30%, mainly in patients with relapsing most (about 75%), relapse after chemotherapy to poor results.

For the treatment of recurrent ovarian cancer chemotherapy drugs many, no less than 10 species, but only clinical remission rate of 20% to 30%, no progress median survival time (PFS) for 2 to 6 months, the median overall survival (OS) for six to 12 months. Therefore, to improve the efficacy of chemotherapy drugs delay, but the development of new drugs is very difficult, efficient use of existing drugs is an effective way to <BR>.

Tags: cancer, cases, chemotherapy, cisplatin, clinical, drug, drugs, early, eat, exploration, gene, group, method, ovarian, p53, paclitaxel, patients, pmtc, poor, positive, prognosis, rate, second, study, survival, taxol, therapy, time, treatment, tumor, tumors

A large number of pre-clinical data and the right abdominal anatomy, physiology and biology of ovarian cancer have suggested that understanding, abdominal local cytotoxic drug treatment for ovarian cancer is very reasonable. Intraperitoneal chemotherapy Phase I clinical trial confirmed the chemotherapy drugs and intraperitoneal chemotherapy safety of the technology itself, confirmed the intraperitoneal chemotherapy in the pharmacokinetic advantages.

In some multi-center Phase II clinical trials, surgical results confirmed that about 20% to 40% of second-tier category to cisplatin-based chemotherapy in patients with celiac complete remission, the part of the residual cancer patients <0.5 cm before  acceptable to platinum-based chemotherapy effective systemic System .

Tags: abdominal, administration, age, cancer, carboplatin, cause, chemotherapy, cisplatin, clinical, days, drug, drugs, eat, group, incidence, infusion, injection, intraperitoneal, intravenous, ovarian, paclitaxel, pain, patients, rate, reduce, residual, second, study, surgical, survival, taxol, therapy, time, toxicity, treatment, tumor

Ovarian cancer

Tags: abdominal, age, benign, bleeding, blood, body, cancer, cause, cell, cells, clinical, cyst, examination, fat, growth, head, malignant, mass, ovarian, pain, second, symptoms, tumor, tumors, women

Disease Overview

Tags: age, breast, cancer, carcinoma, cause, cell, cells, chemotherapy, children, diagnosis, early, eat, ert, fat, gene, group, incidence, increased, knowledge, life, lymph, malignant, metastatic, ovarian, patients, preventive, radiotherapy, rate, risk, second, surface, surgery, survival, symptoms, tea, therapy, time, treatment, tumor, tumors, uterine, women

Epithelial ovarian cancer in the United States is a relatively rare in Gynecologic Oncology, 2004, there were approximately 25,580 cases of new onset patients, 16,090 cases patients died. The majority of patients with advanced cancer, treatment for surgical resection and postoperative to platinum-based chemotherapy. During the past 10 years, chemotherapy improved survival rates improve, and recurrent tumor treatment more effective. In addition, the genetic risk factors for making in-depth understanding of the prevention strategy to become individualized approach to bilateral tubal women - ovarian surgery. This report summarized the clinical characteristics of epithelial ovarian, after reports focus on the treatment of the latest developments.

Tags: age, brca1, breast, cancer, carcinoma, cases, cause, chemotherapy, clinical, diagnosis, drug, drugs, early, eat, ert, estrogen, examination, family, gene, group, groups, history, incidence, increased, life, malignant, mutation, ovarian, ovary, patients, pelvic, preventive, protein, rate, reduce, resection, risk, screening, second, study, surface, surgery, surgical, survival, syndrome, therapy, time, treatment, tumor, usually, women